TrialInternational journal of clinical oncology2019

Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration.

Keisuke Shigeta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.